Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Total Stockholders' Equity	Common Stock	Additional Paid In Capital	Distributions in Excess of Cumulative Earnings	Accumulated Other Comprehensive Income	Non-controlling Interests
Balance at beginning of period (in shares) at Dec. 31, 2022			142,379,655
Balance at beginning of period at Dec. 31, 2022	$ 2,496,771	$ 2,488,261	$ 1,424	$ 2,563,305	$ (117,187)	$ 40,719	$ 8,510
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance (in shares)			6,248,695
Common stock issuance	147,279	147,279	$ 62	147,217
Common stock withheld related to net share settlement of equity awards	(2,745)	(2,745)			(2,745)
Costs related to issuance of common stock	(444)	(444)		(444)
Other comprehensive income (loss)	(14,828)	(14,737)				(14,737)	(91)
Equity based compensation expense (in shares)			209,767
Equity based compensation expense	2,721	2,721	$ 2	2,719
Dividends declared on common stock and OP Units	(41,183)	(41,030)			(41,030)		(153)
Net income	43,056	42,896			42,896		160
Balance at end of period (in shares) at Mar. 31, 2023			148,838,117
Balance at end of period at Mar. 31, 2023	$ 2,630,627	2,622,201	$ 1,488	2,712,797	(118,066)	25,982	8,426
Balance at beginning of period (in shares) at Dec. 31, 2023	164,635,150		164,635,150
Balance at beginning of period at Dec. 31, 2023	$ 2,987,002	2,978,579	$ 1,646	3,078,459	(105,545)	4,019	8,423
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance (in shares)			10,508,096
Common stock issuance	244,735	244,735	$ 105	244,630
Common stock withheld related to net share settlement of equity awards	(3,277)	(3,277)			(3,277)
Costs related to issuance of common stock	(366)	(366)		(366)
Other comprehensive income (loss)	19,631	19,575				19,575	56
Equity based compensation expense (in shares)			163,140
Equity based compensation expense	2,947	2,947	$ 2	2,945
Dividends declared on common stock and OP Units	(50,236)	(50,079)			(50,079)		(157)
Net income	$ 47,123	46,975			46,975		148
Balance at end of period (in shares) at Mar. 31, 2024	175,306,386		175,306,386
Balance at end of period at Mar. 31, 2024	$ 3,247,559	$ 3,239,089	$ 1,753	$ 3,325,668	$ (111,926)	$ 23,594	$ 8,470